Korsten, Peter

[["dc.bibliographiccitation.firstpage","1307"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Chest"],["dc.bibliographiccitation.lastpage","1308"],["dc.bibliographiccitation.volume","159"],["dc.contributor.author","Sweiss, Nadera J."],["dc.contributor.author","Korsten, Peter"],["dc.contributor.author","Baughman, Robert P."],["dc.contributor.author","Culver, Daniel A."],["dc.contributor.author","Judson, Marc A."],["dc.date.accessioned","2021-04-14T08:29:02Z"],["dc.date.available","2021-04-14T08:29:02Z"],["dc.date.issued","2021"],["dc.identifier.doi","10.1016/j.chest.2020.10.005"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/82773"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-399"],["dc.relation.issn","0012-3692"],["dc.title","Response"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","1173"],["dc.bibliographiccitation.issue","8"],["dc.bibliographiccitation.journal","Arthritis Care & Research"],["dc.bibliographiccitation.lastpage","1179"],["dc.bibliographiccitation.volume","68"],["dc.contributor.author","Korsten, Peter"],["dc.contributor.author","Konig, Maximilian F."],["dc.contributor.author","Mueller, Georg Anton"],["dc.contributor.author","Barrantes-Freer, Alonso"],["dc.contributor.author","Sweiss, Nadera J."],["dc.contributor.author","Vasko, Radovan"],["dc.date.accessioned","2018-11-07T10:10:47Z"],["dc.date.available","2018-11-07T10:10:47Z"],["dc.date.issued","2016"],["dc.identifier.doi","10.1002/acr.22781"],["dc.identifier.isi","000383501900015"],["dc.identifier.pmid","26555558"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/39927"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.relation.issn","2151-4658"],["dc.relation.issn","2151-464X"],["dc.title","Respiratory Distress and Nephropathy in a Young Male With Small-Joint Polyarthritis"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","516"],["dc.bibliographiccitation.issue","5"],["dc.bibliographiccitation.journal","Current Opinion in Pulmonary Medicine"],["dc.bibliographiccitation.lastpage","523"],["dc.bibliographiccitation.volume","19"],["dc.contributor.author","Korsten, Peter"],["dc.contributor.author","Mirsaeidi, Mehdi"],["dc.contributor.author","Sweiss, Nadera J."],["dc.date.accessioned","2018-11-07T09:20:18Z"],["dc.date.available","2018-11-07T09:20:18Z"],["dc.date.issued","2013"],["dc.description.abstract","Purpose of reviewNone of the medications used in clinical practice to treat sarcoidosis have been approved by the regulatory authorities. Understanding how to use disease-modifying antisarcoid drugs, however, is essential for physicians treating patients with sarcoidosis. This review summarizes the recent studies of medications used for sarcoidosis with a focus on nonsteroidal therapies. Studies from 2006 to 2013 were considered for review to update clinicians on the most relevant literature published over the last few years.Recent findingsSeveral recently published pieces of evidence have helped expand our ability to more appropriately sequence second-line and third-line therapies for sarcoidosis. For instance, methotrexate and azathioprine may be useful and well tolerated medications as second-line treatment. Mycophenolate mofetil might have a role in neurosarcoidosis. TNF- blockers and other biologics seem to be well tolerated medications for the most severely affected patients.SummaryCorticosteroids remain the first-line therapy for sarcoidosis as many patients never require treatment or only necessitate a short treatment duration. Second-line and third-line therapies described in this article should be used in patients with progressive or refractory disease or when life-threatening complications are evident at the time of presentation."],["dc.description.sponsorship","NHLBI NIH HHS [T32 HL082547]"],["dc.identifier.doi","10.1097/MCP.0b013e3283642ad0"],["dc.identifier.isi","000326587100016"],["dc.identifier.pmid","23884295"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/28852"],["dc.language.iso","en"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.relation.eissn","1070-5287"],["dc.relation.issn","1531-6971"],["dc.title","Nonsteroidal therapy of sarcoidosis"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","150"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Journal of the American College of Surgeons"],["dc.bibliographiccitation.volume","218"],["dc.contributor.author","Shawagfeh, Munir T."],["dc.contributor.author","Korsten, Peter"],["dc.contributor.author","Sawaqed, Ray S."],["dc.contributor.author","Sweiss, Nadera J."],["dc.date.accessioned","2020-05-04T07:22:00Z"],["dc.date.available","2020-05-04T07:22:00Z"],["dc.date.issued","2014"],["dc.description.abstract","Music or no music is a question that has been addressed in many studies, which is why we read with great interest the article, “Effect of noise on auditory processing in the operating room,” by Way and colleagues in the May issue of this journal.1 The study suggested that surgeons demonstrated poorer auditory performance with music than in quiet or with operating room noise. Another recent study also suggested that music might be a potential distractor in operating rooms during urologic procedures.2 There are many studies that try to further elucidate the effects of music on patient factors on one hand (anxiety, stress, need for analgesic drugs, and sedation) and surgeons and surgical staff on the other hand (communication, task performance, speed, and accuracy), as reviewed recently by Moris and Linos.3 In addition, the type of music seems to be important. In a study by Siu and colleagues,4 music with high rhythmicity had beneficial effects on surgical performance in a simulated robotic model, suggesting that music might be of value during skill acquisition and training. In mechanically ventilated patients, patient-directed music reduced anxiety and sedation frequency as compared with noise-cancelling headphones or usual care.5 A caveat of this study was patient selection and lack of standardization of outcomes measures. Also, the findings of this study might not apply to patients who undergo elective surgery. As health care providers, we should be dedicated to keeping the surgical patient safe in the perioperative period and ensuring that care is provided in an optimal environment. Patient safety comes first; it is mandatory that monitors and alarms are audible and necessary measures can be taken in a timely manner. We would like to suggest that volume levels in the operating room should be monitored and balanced to account for the possible beneficial effects on patient satisfaction and surgical performance (which might be positively influenced by music) while not rendering communication between nurses and anesthesiologists difficult. Indeed, all potential distractors and disruptive behaviors pose a threat to patient safety. In the absence of controlled and well-designed studies on the effect of music in the operating room on operating room personnel vigilance and task performance, we cannot definitely answer the question (“music or no music in the operating room?”). Until that time, no general recommendations can be made, and music during intervention still is merely a matter of subjective preference. We acknowledge the fact that on one hand, music might have beneficial effects on patient satisfaction, use of sedative drugs, and surgical performance, while on the other hand, music could be a potential distractor, possibly impending communication. Future work should examine the effects of other nonpatient care activities like reading,6 the role of music in various settings and patient populations, and clear measurements of outcomes. In fact, music is an important aspect of cultural and social life and we as scientists should respect individual preferences of both patients and physicians."],["dc.identifier.doi","10.1016/j.jamcollsurg.2013.09.019"],["dc.identifier.pmid","24355878"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/64542"],["dc.language.iso","en"],["dc.relation.eissn","1879-1190"],["dc.relation.issn","1072-7515"],["dc.title","Noise or silence in the operating room?"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","463"],["dc.bibliographiccitation.issue","4"],["dc.bibliographiccitation.journal","Seminars in Respiratory and Critical Care Medicine"],["dc.bibliographiccitation.lastpage","473"],["dc.bibliographiccitation.volume","31"],["dc.contributor.author","Sweiss, Nadera J."],["dc.contributor.author","Patterson, Karen"],["dc.contributor.author","Sawaqed, Ray"],["dc.contributor.author","Jabbar, Umair"],["dc.contributor.author","Korsten, Peter"],["dc.contributor.author","Hogarth, Kyle"],["dc.contributor.author","Wollman, Robert"],["dc.contributor.author","Garcia, Joe G. N."],["dc.contributor.author","Niewold, Timothy B."],["dc.contributor.author","Baughman, Robert P."],["dc.date.accessioned","2018-11-07T08:41:05Z"],["dc.date.available","2018-11-07T08:41:05Z"],["dc.date.issued","2010"],["dc.description.abstract","Sarcoidosis is a systemic, clinically heterogeneous disease characterized by the development of granulomas. Any organ system can be involved, and patients may present with any number of rheumatologic symptoms. There are no U. S. Food and Drug Administration-approved therapies for the treatment of sarcoidosis. Diagnosing sarcoidosis becomes challenging, particularly when its complications cause patients' symptoms to mimic other conditions, including polymyositis, Sjogren syndrome, or vasculitis. This review presents an overview of the etiology of and biomarkers associated with sarcoidosis. We then provide a detailed description of the rheumatologic manifestations of sarcoidosis and present a treatment algorithm based on current clinical evidence for patients with sarcoid arthritis. The discussion will focus on characteristic findings in patients with sarcoid arthritis, osseous involvement in sarcoidosis, and sarcoid myopathy. Arthritic conditions that sometimes coexist with sarcoidosis are described as well. We present two cases of sarcoidosis with rheumatologic manifestations. Our intent is to encourage a multidisciplinary, translational approach to meet the challenges and difficulties in understanding and treating sarcoidosis."],["dc.identifier.doi","10.1055/s-0030-1262214"],["dc.identifier.isi","000280346900011"],["dc.identifier.pmid","20665396"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/19394"],["dc.language.iso","en"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.relation.issn","1069-3424"],["dc.title","Rheumatologic Manifestations of Sarcoidosis"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","892"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Chest"],["dc.bibliographiccitation.lastpage","895"],["dc.bibliographiccitation.volume","158"],["dc.contributor.author","Sweiss, Nadera J."],["dc.contributor.author","Korsten, Peter"],["dc.contributor.author","Syed, Huzaefah J."],["dc.contributor.author","Syed, Aamer"],["dc.contributor.author","Baughman, Robert P."],["dc.contributor.author","Yee, Arthur M.F."],["dc.contributor.author","Culver, Daniel A."],["dc.contributor.author","Sosenko, Teresa"],["dc.contributor.author","Azuma, Arata"],["dc.contributor.author","Bonella, Francesco"],["dc.contributor.author","Costabel, Ulrich"],["dc.contributor.author","Drake, Wonder P."],["dc.contributor.author","Drent, Marjolein"],["dc.contributor.author","Lower, Elyse E."],["dc.contributor.author","Israel-Biet, Dominique"],["dc.contributor.author","Mostard, Remy L.M."],["dc.contributor.author","Nunes, Hilario"],["dc.contributor.author","Rottoli, Paola"],["dc.contributor.author","Spagnolo, Paolo"],["dc.contributor.author","Wells, Athol U."],["dc.contributor.author","Wuyts, Wim A."],["dc.contributor.author","Judson, Marc A."],["dc.date.accessioned","2021-04-14T08:23:31Z"],["dc.date.available","2021-04-14T08:23:31Z"],["dc.date.issued","2020"],["dc.identifier.doi","10.1016/j.chest.2020.04.033"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/80945"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-399"],["dc.relation.issn","0012-3692"],["dc.title","When the Game Changes"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","1983"],["dc.bibliographiccitation.lastpage","1996"],["dc.contributor.author","Sweiss, Nadera J."],["dc.contributor.author","Korsten, Peter"],["dc.contributor.author","Baughman, Robert P."],["dc.date.accessioned","2020-05-04T07:25:53Z"],["dc.date.available","2020-05-04T07:25:53Z"],["dc.date.issued","2017"],["dc.description.edition","10"],["dc.identifier.doi","10.1016/B978-0-323-31696-5.00117-0"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/64546"],["dc.language.iso","en"],["dc.publisher","Elsevier"],["dc.relation.isbn","978-0-323-31696-5"],["dc.relation.ispartof","Kelley and Firestein's Textbook of Rheumatology"],["dc.title","Sarcoidosis"],["dc.type","book_chapter"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","E17"],["dc.bibliographiccitation.issue","6"],["dc.bibliographiccitation.journal","American Journal of Kidney Diseases"],["dc.bibliographiccitation.lastpage","E21"],["dc.bibliographiccitation.volume","56"],["dc.contributor.author","Korsten, Peter"],["dc.contributor.author","Sweiss, Nadera J."],["dc.contributor.author","Nagorsnik, Ulf"],["dc.contributor.author","Niewold, Timothy B."],["dc.contributor.author","Groene, Hermann-Josef"],["dc.contributor.author","Gross, Oliver"],["dc.contributor.author","Mueller, Georg Anton"],["dc.date.accessioned","2018-11-07T08:35:56Z"],["dc.date.available","2018-11-07T08:35:56Z"],["dc.date.issued","2010"],["dc.description.abstract","Tumor necrosis factor alpha (TNF-alpha) inhibitors are used in the treatment of rheumatoid arthritis, psoriasis, psoriatic arthritis, Crohn disease, ankylosing spondylitis, and juvenile idiopathic arthritis. Use of TNF inhibitors is associated with the induction of autoimmunity (systemic lupus erythematosus, vasculitis, psoriasis, and sarcoidosis/sarcoid-like granulomas). We report a case of interstitial granulomatous nephritis in a patient with ankylosing spondylitis after 18 months of treatment with adalimumab. Previously reported cases of sarcoid-like reactions secondary to the use of TNF-alpha inhibitors involved the liver, lung, lymph nodes, central nervous system, and skin. Granulomatous nephritis after adalimumab treatment has not been described. Close observation of patients undergoing treatment with TNF inhibitors for evolving signs and symptoms of autoimmunity is required. Organ involvement is unpredictable, which makes correct diagnosis and management extremely challenging. Am J Kidney Dis 56:e17-e21. (C) 2010 by the National Kidney Foundation, Inc."],["dc.identifier.doi","10.1053/j.ajkd.2010.08.019"],["dc.identifier.isi","000284401800001"],["dc.identifier.pmid","20974510"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/18197"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","W B Saunders Co-elsevier Inc"],["dc.relation.issn","0272-6386"],["dc.title","Drug-Induced Granulomatous Interstitial Nephritis in a Patient With Ankylosing Spondylitis During Therapy With Adalimumab"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]